These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16845259)

  • 1. Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.
    Ly LT; Cavanagh HD; Petroll WM
    Eye Contact Lens; 2006 Jul; 32(4):161-5. PubMed ID: 16845259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of moxifloxacin as shown in animal and in vitro studies.
    McGee DH; Holt WF; Kastner PR; Rice RL
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.
    Price MO; Price FW; Maclellan D
    J Cataract Refract Surg; 2005 Nov; 31(11):2137-41. PubMed ID: 16412928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E; Perry HD; Chruscicki DA; Bitterman A; Cohn S; Solomon R
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.
    Herrygers LA; Noecker RJ; Lane LC; Levine JM
    Cornea; 2005 Jan; 24(1):66-71. PubMed ID: 15604869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.
    Sosa AB; Epstein SP; Asbell PA
    Cornea; 2008 Sep; 27(8):930-4. PubMed ID: 18724156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
    Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
    Burka JM; Bower KS; Vanroekel RC; Stutzman RD; Kuzmowych CP; Howard RS
    Am J Ophthalmol; 2005 Jul; 140(1):83-7. PubMed ID: 15953577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy.
    Williams KK; McCartney MD; Rice RL; Wax MB; Hiddemen JW
    Vet Ophthalmol; 2008; 11(5):327-34. PubMed ID: 19046293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of zonula occludens-1 localization in the rabbit corneal epithelium by contact lens-induced hypoxia.
    Yanai R; Ko JA; Morishige N; Chikama T; Ichijima H; Nishida T
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4605-10. PubMed ID: 19474401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%.
    Williams KK; Shepard AR; Rice RL; McCartney MD; Wax MB; Hiddemen JW
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):517-25. PubMed ID: 18001231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
    Shin JH; Lee HB; Park HY
    Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model.
    Barequet IS; Habot-Wilner Z; Lavinsky F; Ziv H; Belkin M; Rosner M
    Cornea; 2007 Jun; 26(5):606-9. PubMed ID: 17525660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy.
    Kovoor TA; Kim AS; McCulley JP; Cavanagh HD; Jester JV; Bugde AC; Petroll WM
    Eye Contact Lens; 2004 Apr; 30(2):90-4. PubMed ID: 15260356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study.
    Kleinmann G; Apple DJ; Chew J; Stevens S; Hunter B; Larson S; Mamalis N; Olson RJ
    J Cataract Refract Surg; 2006 Apr; 32(4):652-4. PubMed ID: 16698489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
    Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ
    J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.
    Miyake T; Ito N; Tajima K; Goto H; Furukawa T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1035-41. PubMed ID: 22282216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].
    Kernt M; Hirneiss C; Neubauer AS; Liegl RG; Eibl KH; Wolf A; de Kaspar H; Ulbig MW; Kampik A
    Ophthalmologe; 2010 Aug; 107(8):720-7. PubMed ID: 19756636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.